´Ý±â
TaKaRa
Á¦Ç°¸í/Á¦Ç°ÄÚµå
Å°¿öµå°Ë»ö
°Ë»ö
´Ý±â
  • °í°´Áö¿ø 
  • ¾÷¹«¾È³»¦¢Á¦Ç°¹®ÀÇ
  • ÀüÈ­¹øÈ£¦¢02-2081-2510
  • Email     ¦¢[email protected]
  • ´ëÀüÁö»ç 
  • ¾÷¹«¾È³»¦¢´ëÀü/ÃæûÁö¿ª ÁÖ¹®, Á¦Ç°¹®ÀÇ
  • ÀüÈ­¹øÈ£¦¢042-828-6525
  • Email     ¦¢[email protected]
  • ¾÷¹«½Ã°£¾È³»
  • [ Æò¡¡¡¡ÀÏ ] 09 : 00 ~ 18 : 00 ¦¢ [ Á¡½É½Ã°£ ] 12 : 00 ~ 13 : 00
  • Å䡤ÀÏ¿äÀÏ, °øÈÞÀÏÀº ÈÞ¹«ÀÔ´Ï´Ù.

FLAG tag ´Ü¹éÁú »ý»ê

-

Á¦Á¶»ç Á¦Ç°ÄÚµå Á¦Ç°¸í ¿ë·® °¡°Ý
(ºÎ°¡¼¼º°µµ)
ºñ°í »ç¿ëÀڸŴº¾ó
µ¥ÀÌÅÍ°¡ ¾ø½À´Ï´Ù

  • ±¤¹üÀ§ÇÏ°Ô »ç¿ëµÇ´Â Ä£¼ö¼º peptide tagÀÎ DYKDDDDK(FLAG¼­¿­)tag ÀÌ¿ë
  • ¸ñÀû ´Ü¹éÁúÀÇ N-¸»´Ü ¶Ç´Â C-¸»´ÜÀÇ DYKDDDDK(FLAG¼­¿­)tagÀ» À¶ÇÕÇÏ´Â ¹ßÇö º¤ÅÍ
Á¦Ç° ¼³¸í
pCMV-(DYKDDDDK)º¤ÅÍ´ÂFLAG¼­¿­tag·Î ¾Ë·ÁÁ® ÀÖ´Â DYKDDDDK tag¸¦ ¸ñÀû ´Ü¹éÁú°ú À¶ÇÕ½ÃÄÑ ¹ßÇö ½ÃÅ°´Â Æ÷À¯·ù ¼¼Æ÷¿ë ¹ßÇö tagÀÌ´Ù.
DYKDDDDK(FLAG¼­¿­) epitopeÀº ¸é¿ª¹ÝÀÀ¼ºÀ» º¸±â À§ÇÑ ¸é¿ªÄ§°­½ÇÇè(immunoprecipitation)¿¡ Àû´çÇϸç Anti-DYKDDDDK Antibody¸¦ ÀÌ¿ëÇϸé western blotÀ¸·Î DYKDDDDK tag À¶ÇÕ ´Ü¹éÁúÀ» °£´ÜÈ÷ °ËÃâÇÒ ¼ö ÀÖ´Ù.

pCMV-DYKDDDDK Vector Set´Â DYKDDDDK tag¸¦ ¸ñÀû ´Ü¹éÁúÀÇ N¸»´Ü¿¡ ºÎ°¡ÇÑ º¤ÅÍ¿Í C¸»´Ü¿¡ ºÎ°¡ÇÑ º¤ÅÍ·Î ±¸¼ºµÇ¾î ÀÖ´Ù. ÀÌ º¤Å͵éÀº ¿©·¯ °¡Áö Æ÷À¯·ù ¼¼Æ÷¿¡¼­ ³ôÀº ·¹º§ÀÇ ´Ü¹éÁú ¹ßÇöÀ» °¡´ÉÇÏ°Ô ÇÏ´Â CMV ÇÁ·Î¸ðÅ͸¦ °®°í ÀÖ´Ù.

¡¼º¤ÅÍ ±×¸²¡½


Immunoprecipitaition Buffer Set´Â Anti-DYKDDDDK Beads¸¦ ÀÌ¿ëÇÑ ¸é¿ª ħ°­¿¡ ÃÖÀûÈ­µÈ ¹öÆÛ·Î ³·Àº ¹é±×¶ó¿îµå¸¦ °¡´ÉÇÏ°Ô ÇÑ´Ù.

±×¸²1£®Anti-DYKDDDDK Antibody¿¡ ÀÇÇÑ DYKDDDDK tag À¶ÇÕ ´Ü¹éÁúÀÇ °ËÃâ
Clontech¡¯s Anti-DYKDDDDK Antibody provides the same great sensitivity as the competitor's antibody on Western blots. Western blots were made using serial dilutions of N-terminally tagged AcGFP1 lysates obtained from 293 cells, and developed using either Clontech¡¯s Anti-DYKDDDDK Antibody or Competitor S¡®s anti-FLAG antibody.

³»¿ë

pCMV-DYKDDDDK Vector Set (Code 635688)
  • pCMV-(DYKDDDDK)-N Vector
  • pCMV-(DYKDDDDK)-C Vector
º¸Á¸
pCMV-DYKDDDDK Vector Set, Anti-DYKDDDDK Antibody : -20¡É

*FLAG¢ç´Â Sigma-Aldrich »çÀÇ µî·Ï»óÇ¥ÀÔ´Ï´Ù.

Keyword : flag